ABOUT
Leading the way to targeted precision immunotherapy
Focused on engineering first-in-class therapies with high specificity by our p:HLA target discovery and antibody design infrastructure. We are leveraging foundational AI with in-house data generation, enabling rapid target validation and drug candidate design.
OUR MISSION
Precision immunotherapy for
hard-to-treat diseases

By harnessing the power of AI and synthetic biology, we are defining new standards for TCRm Antibody development. We push to keep developing potent and safe immunotherapies for patients with no treatment options.
OUR VALUES
Our driving force behind our mission to revolutionize precision immunotherapy
With an unwavering commitment to innovation, ethical excellence, and a profound dedication to patients our values are the guiding principles propelling our mission to redefine the landscape of immunotherapy and positively impact lives worldwide.
Care
Is our ambition to improve the life of cancer patients.
Team-thinking
It is the key to delivering innovative solutions.
Personal growth
We pursue growth and learning.
Excellence
We strive to be the best in what we do.
Integrity
We work on the things that matter.
Meet our team
CEO
Jan-Jaap Verhoef (PhD)
Head of Bioinformatics
Simona Aufiero (PhD)
Head of antibody discovery
Joanna Turley (PhD)
Bioinformatician
Roberto Fornelino
ASSOCIATE SCIENTIST
Rico Bas
Junior bioinformatician
Nick Bounatsos
Junior Scientist
Aurelia Ciarelli
Our partners
With the funds of the European Union, Imuno has been able to accelerate the development of its screening platform and further validation of antibodies targeting immune escape tumors. .
Ourlocation
Situated in the vibrant city of Leiden, our company strategically leverages its location at the crossroads of innovation, tapping into the dynamic ecosystem of the city’s renowned life sciences community.